Diseases 8.3

                                                   8.3 Spreading It

Learning Outcomes:
6. Describe how infe...
Diseases 8.3




Influenza – a deadly disease
                                                                 During Worl...
Diseases 8.3




Evaluate your behaviour: Do you sneeze or cough into your sleeve or shoulder? Vs. Sneezing into
your hand...
Diseases 8.3
A highly virulent strain or type of flu (Flu A) will be quick to infect, with a short incubation period and
t...
Diseases 8.3


For Your Information: For Your Information: Adjuvants
Plain formulations of vaccine are only moderately eff...
Diseases 8.3




                          National Institute of Allergy and Infectious Diseases

The Center for Disease C...
Diseases 8.3
susceptible to the strain would be individuals that have chronic conditions, the very young, the
very old and...
Diseases 8.3
b. The new shape of the hemagluttinin allows the virus to bind more easily to cells of our
   respitory tract...
Upcoming SlideShare
Loading in...5
×

8.3 Spreading It

347

Published on

UBC Bio 111 - Intro to Biology

Published in: Education, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
347
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "8.3 Spreading It"

  1. 1. Diseases 8.3 8.3 Spreading It Learning Outcomes: 6. Describe how infectious diseases spread. For today: Watch the 5 min video Cholera: domesticating disease http://www.pbs.org/wgbh/evolution/library/10/4/l_104_01.html Readings for next week: Chapter 5: 109-130, Reading Quiz due Monday Nov 2 Antibiotics Natural antibiotics are produced by different strains of fungi against certain bacteria. Fungi secrete a chemical which targets a structure or process unique to bacterial cells. In this way bacteria are killed but not fungi. Man-made antibiotics also exist, which target processes or cell structures found in the pathogen but not shared by the host. QUESTION: Although there are some antibiotics against protists like Giardia lamblia and Trichomonas vaginalis, it is generally harder to find antibiotics against protists and there is often a greater chance that some of these antibiotics may make people sick. Considering what you know about protist cells why might this be Giardia lamblia Trichomonas vaginalis http://www.biotech- http://www.uthscsa.edu/missio weblog.com/50226711/giardia_l n/spring00/std.htm amblia_genome_sequenced.php Some strains of pathogenic bacteria are able to “fight back” by producing toxins. These toxins can be found attached on the outside of the pathogen and act locally at the sight of the bacterial infection or some strains secrete toxins which travel through the blood stream of the host and can target cells far from the site of the initial bacterial infection. How do toxins make the host sick? Like antibiotics they target processes or cellular structures found in the host but absent from the pathogen. Examples: diphtheria toxin –stops protein synthesis in Eukaryotes, killing cells cholera toxin – specific to cells lining the intestine, it causes these cells to keep their chloride ion channels open so that intestinal cells secrete chloride ions and water into the lumen of the intestine causing dehydration and diarrhea. tetanus toxin –prevents some nerve cells from transmitting signals to muscles resulting in a type of spastic paralysis. QUESTION: What natural toxin produced by dinoflagellates have we discussed before? What does it target that will have no effect on dinoflagellates? Neurotoxin – paralysis. (dinofagellates cause red tide)
  2. 2. Diseases 8.3 Influenza – a deadly disease During World War I a new strain of flu virus infected troops in the trenches of the battle fields. These individuals were quickly moved into hospitals where most patients had weak or compromised immune systems. The flu spread quickly through hospitals into battle fields and into the general public. The pathogen was transmitted across the oceans as troops returned home. In the UK 280,000 died while in the US 600,000 died. Over 40 million died world wide (8 million in Spain alone, hence the frequent reference to this outbreak as the Spanish flu). Since that time the flu has been one of the most well studied diseases in the world. How do you know if you have H1N1? a. You have a runny nose and are sneezing b. You have a fever and your body aches c. Your feel very tired and lethargic d. You have a runny nose, sneezing, a sore throat but no fever e. You have a fever, body aches and feel tired and lethargic How do you know your condition is not a cold? Cold causing adenoviruses are specialized to attach to the epithelial cells of the respiratory tract. The symptoms differ from H1N1 in that…. No fever, runny nose, headache, possible coughing Epidemiology is the study of the transmission, frequency or prevalence of a disease through a population. Epidemiology is the foundation of public health where officials are charged with identifying outbreaks and occurrences of diseases and enforcing containment of contagious diseases by quarantine. They investigate and identify the agents of transfer and either remove or limit the effectiveness of the agents. Epidemics are higher than normal incidence of the disease and may be localized where as pandemics are worldwide e.g., the Flu pandemic of 1918. Undetected transmission of pathogens Airborne pathogens such as droplets from the nose and mouth are transmitted by coughing and sneezing. Alternately the pathogen may be transmitted through direct or close contact (< 1 m) or transferred from surfaces (your hands pick up pathogens from door knobs etc.)
  3. 3. Diseases 8.3 Evaluate your behaviour: Do you sneeze or cough into your sleeve or shoulder? Vs. Sneezing into your hand (used to touch other surfaces) When you sniff do you wipe your nose with a tissue? Do you reuse the tissue? Where do you dispose of it? OR Do you rub your hand under your nose? How often do you wash your hands? After you get off of transit where you held onto poles and straps held by others? After you come in from outside when handling door handles? Do you wash your hands thoroughly when you go to the bathroom? SURVEY: How many times a day do you wash your hands? a. 0-3 times b. 4-8 times c. 9-12 times d. Only 3 or 4 hand washes, but plenty of sanitizer e. other Following transmission the pathogen must pass through the skin or lining of respiratory system to infect bodily tissues where they begin to grow and reproduce. The incubation period where the individual is infected but shows no symptoms varies among pathogens and the vigor of the host’s immune system. (~24 hours for H1N1) The symptoms of the disease may be caused directly by the pathogens (effect of toxins) or by your body’s response to the pathogens. An individual may not show symptoms until such time as the pathogen has increased sufficiently to illicit an effect on the immune system. The infected individuals can be carriers and capable of infecting others that they contact. A fine balance: Pathogens have a special interaction with the host. They depend on the host for survival and reproduction, but if they kill the host then their ability to spread decreases. How likely are pathogens of different levels of virulence to be transmitted, to spread? from: http://evolution.berkeley.edu/evolibrary/news/071201_adenovirus Virulence is the FYI: The H1N1 virus can survive on hard surfaces (eg door knobs) extent of microorganisms for 24-48 hrs., on soft surfaces (eg towel) for 15 min. and on to cause disease or the hands for 5 min. Dried secretions on hands can be transmitted to severity of a pathogen the eyes, nose and mouth (How often do you touch your face?) e.g., Imagine Influenza A is highly virulent while type C is mild.
  4. 4. Diseases 8.3 A highly virulent strain or type of flu (Flu A) will be quick to infect, with a short incubation period and therefore the host immune system has little time to respond. These infections are often fatal. An infection of medium virulence (Flu B) may develop over 3 to 10 days before the symptoms become apparent. The immune system is actively combating the pathogen. A pathogen with low virulence (Flu C) induces mild symptoms or they many not be noticeable. The pathogen has a slow rate of production and is a feasible strategy for infecting long-lived hosts. Is there an "optimal virulence”? Watch the 5 min video with Dr. Paul Ewald. http://www.pbs.org/wgbh/evolution/library/10/4/l_104_01.html QUESTION: After watching the video and considering how influenza is transmitted, how ‘optimal’ is the virulence of H1N1? Why do we keep getting colds and influenzas? The genetic material from different strains of viruses can recombine to produce new strains. The new combination of genetic information results in the production of new surface proteins that the human immune system has never encountered and doesn’t recognize. This can occur where humans live closely with other animals such as ducks, pigs and chicken that harbour strains of viruses (antigenic variation occurs between different species). Humans have no immediate antibody protection to these new strains and depending on the virulence of the pathogen this can lead to epidemics (e.g., SARS and H1N1). For influenza (H_N_) the various strains are named depending on what variant they have of the hemaggluttinin protein (H_) and what variant they have of the neuraminadase protein (N_) Different strains are adapted to attach to receptors on cells of the respiratory tract of specific animals. Pigs happen to have both the human type receptors and the avian (bird) type receptors. This means that in a pig, viruses from swine (pigs), birds and humans can all recombine into a new form, which is what happened for H1N1. It is a triply recombined virus made from two different swine viruses, one bird virus and one human virus. Fortunately since it appeared last spring it has not seemed to have undergone much further mutation. This is good news because the form of the H1N1 virus for the vaccine was chosen in June. It takes 4-5 months to grow the virus inside fertilized chicken eggs and 3 more months to test it. During this time it is possible for the virus to mutate so that vaccine is not as effective. This has not happened.
  5. 5. Diseases 8.3 For Your Information: For Your Information: Adjuvants Plain formulations of vaccine are only moderately effective against seasonal flu viruses (60-70% effective). For H1N1 there was concern that individuals would require two doses of this regular formulation for it to be effective and we would not be able to produce enough. Adjuvants are immune boosters that cause a faster stronger response while allowing less antigen (dead virus particles) to be used. Different types of adjuvants have been used for many vaccines in the past such as all the shots you had in childhood. In order for people to only need one dose of the H1N1 vaccine it was decide to add adjuvants. The type of adjuvant added to the H1N1 vaccine in Canada has already been used for the last 10 years in Europe on over 25 million people. This particular adjuvant contains: -squalene, a natural component of human blood cell membranes and a precursor of cholesterol and vitamin D -alpha tocopherol (vitamin E) 1/3rd of your daily recommended intake -polysorbate, a detergent which emulsifies oils When mixed together this adjuvant makes oil droplets which, when injected, cause a local tissue reaction. They cause macrophages to gather up the viral antigens, travel to the lymph nodes and present the antigens to the B and T cells to allow them to respond. The response caused by the adjuvant at the site of injection is short-lived because the oil droplets dissolve. However, by causing the macrophages to bring the antigens to the immune cells the antibody production is fast and strong. Occasionally there is a little redness and swelling at the site of injection for 1-2 days. There has never been any auto-immune response observed. In the Canada adjuvanted vaccine is being distributed to all people except to pregnant women in their last trimester. Those women are getting unadjuvanted vaccine because although the adjuvant is believed to be safe based on a large dataset, there is even more data (25 years worth) that unadjuvanted vaccine has never harmed pregnant women. In the US, unadjuvanted vaccine is being distributed (60-70% effective remember). Doctors believe the Canadian adjuvanted vaccine will be more effective.
  6. 6. Diseases 8.3 National Institute of Allergy and Infectious Diseases The Center for Disease Control and Prevention (CDC) the World Health Organization (WHO) track contagious diseases such as the influenza virus. With systematic surveillance and reporting of local outbreaks they develop models of disease transmission and virulence. They promote means of containing the disease and make recommendations for specific vaccine components. The small changes in the regular flu viruses from year to year are called antigenic drift (eg small changes in last year’s virus H3N2). When we get a large change (whole new strain like H1N1) where very few have immunity it is called an antigenic shift. When no one has immunity to a new strain, epidemiologists expect at least 50% of the population to become infected. Depending on the virulence of the strain between one third to two thirds of those infected will become sick. A conservative estimate of approximately 25% of the whole population will become ill, most of which would require hospitalization. The most
  7. 7. Diseases 8.3 susceptible to the strain would be individuals that have chronic conditions, the very young, the very old and those with weak immune systems. The seasonal flu kills 700 to 2500 people per year in Canada. The greatest cause of seasonal flu-related deaths is due to pneumonia. The bacterium invades after the flu depletes and weakens the body’s defense mechanism and significantly decreases the chances of patient survival. Epidemiologists have closely examined the data on who got H1N1 in Australia and New Zealand, which have just finished their winter flu season and had no vaccine. They saw that more males were hospitalized. The largest number of cases by far were in 0-4 year olds. There were also twice as many cases as usual in 18-30 yr olds and 30-50 year olds. The normal seasonal flu usually most strongly affects small children and the elderly. Because a variety of H1N1 existed before 1957, people born before that time that had the flu are protected against H1N1. Based on the data in the southern hemisphere we expect 8-10 deaths in BC, 130 hospitalizations (with the largest group being children under 5) and we expect 5-6 patients in the ICU per week. Question: Researchers predict a lower number of deaths from the flu this year compared to the regular seasonal flu. Why? The most susceptible to becoming very sick (the elderly) have some degree of immunity. Question (asked by one of Wed. nights H1N1 seminar attendee’s): “Why should a healthy 55 year old woman who never gets the seasonal flu vaccine and never gets sick with seasonal flu bother getting the H1N1 vaccine?” If you were the doctor what would you say? Create your own pandemic at this website: http://www.awfulgames.com/games/pandemic/ How do we stop epidemics? Preventative measures include: Washing hands frequently Ensuring clean water supply Ensuring proper food preparation Medical treatments include: Vaccines (for some viruses) Antiviral drugs (Tamaflu and Relenza) Antibiotics, will kill bacterial pathogens only Non-pharmaceutical treatments: Washing hands, masks Social distancing – avoid close person to person contact (ban public gatherings, shut down mass transit, close schools) Contain and quarantine all outbreaks of contagious diseases Question: Will you get vaccinated against H1N1? Why or why not? Question: What is the most likely reason we get sick when the virus mutates? a. We do not have a large pool 78 of memory cells and antibodies which recognize the new shapes
  8. 8. Diseases 8.3 b. The new shape of the hemagluttinin allows the virus to bind more easily to cells of our respitory tract c. The new shape of the hemagluttinin allows it to more easily transfer it’s genetic material into cells

×